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http://www.cardiothoracicsurgery.org/content/7/1/106RESEARCH ARTICLE Open AccessUse of a sealant to prevent prolonged air leaks
after lung resection: a prospective randomized
study
Cosimo Lequaglie1,3*, Gabriella Giudice1, Rita Marasco1, Aniello Della Morte1 and Massimiliano Gallo2Abstract
Background: Pulmonary air leaks are common complications of lung resection and result in prolonged hospital
stays and increased costs. The purpose of this study was to investigate whether, compared with standard care, the
use of a synthetic polyethylene glycol matrix (CoSealW) could reduce air leaks detected by means of a digital chest
drain system (DigiVent™), in patients undergoing lung resection (sutures and/or staples alone).
Methods: Patients who intraoperatively showed moderate or severe air leaks (evaluated by water submersion tests)
were intraoperatively randomized to receive just sutures/staples (control group) or sutures/staples plus CoSealW
(sealant group). Differences among the groups in terms of air leaks, prolonged air leaks, time to chest tube removal,
length of hospital stay and related costs were assessed.
Results: In total, 216 lung resection patients completed the study. Nineteen patients (18.1%) in the control group
and 12 (10.8%) patients in the sealant group experienced postoperative air leaks, while a prolonged air leak was
recorded in 11.4% (n = 12) of patients in the control group and 2.7% (n = 3) of patients in the sealant group. The
difference in the incidence of air leaks and prolonged air leaks between the two groups was statistically significant
(p = 0.0002 and p = 0.0013). The mean length of hospital stay was significantly shorter in the sealant group (4 days)
than the control group (8 days) (p = 0.0001). We also observed lower costs in the sealant group than the control
group.
Conclusion: The use of CoSealW may decrease the occurrence and severity of postoperative air leaks after lung
resection and is associated with shorter hospital stay.
Trial registration: Not registered. The trial was approved by the Institutional Review Board of the IRCCS-CROB
Basilicata Regional Cancer Institute, Rionero in Vulture, Italy.
Keywords: Air leak, Surgical sealant, Digital chest drainBackground
Pulmonary air leaks are a common complication in
patients undergoing elective lung resection and result in
prolonged hospital stays and greater healthcare costs [1].
‘Prolonged’ air leaks (PAL) have previously been defined
as leakages lasting beyond the 7th postoperative day [2].
However, with the aim of safely discharging patients on
the 4th–5th postoperative day, it has been suggested that* Correspondence: cosimo.lequaglie@crob.it
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reproduction in any medium, provided the orthe definition of PAL should be modified to include any
leak lasting longer than five days [3].
Major risk factors for developing pulmonary air leaks
include emphysema, diabetes mellitus, incomplete inter-
lobar fissures, the presence of pleural adhesions, and low
levels of serum albumin and cholinesterase; other factors
that can cause pulmonary air leaks include the creation
of new fissures, dissection of adhesions, manipulation of
the lung, and suturing with staplers [4].
Despite the use of techniques developed to minimize
the occurrence of air leaks, such as pleural tenting after
upper lobe resection, phrenic nerve crush, pneumoperi-
toneum and fissureless surgery [5-8], PALs still have anral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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ary resection and are often accompanied by a series of
events, that may have a negative impact on the patient’s
recovery, prolong the length of stay and raise hospital
costs. Complications such as these underlie the high
level of interest shown in the international literature for
a phenomenon that could be considered as widespread
as it is ambiguous.
The preferred method to reduce air leaks is to prevent
them from occurring; therefore, care should be taken to
perform an accurate dissection of the structures along
well-defined anatomical planes between the segments
and lobes of the lung. Nevertheless, attention has
focused on modifying chest drains to allow accurate
measurement of transpleural air flows and towards the
use of products that aim to prevent parenchymal air
leaks.
The use of traditional chest drains to detect air leaks is
essentially analogical, as it is based on the principle of
identifying air bubbles on the surface of a water valve
and thus is largely dependent on the observers’ impres-
sions. Recently, digital pleural drainage units, the proto-
type of which is the DigiVent™ (Millicore A.B., Sweden),
have allowed measurement and direct estimation of
transpleural air flows (in ml/min) and pleural pressures
(pi, inspiratory pressure and pe, expiratory pressure, in
cm H2O), measured extemporaneously and according to
a cumulative reading taken over 1, 3 and 6 h. Further
details of the characteristics of the DigiVent™ system
have been described previously [9-13].
The treatment of air leaks ranges from direct suture with
thread or staples, to cauterization or laser vaporization; or
from the simple use of Heimlich valves until the leak
resolves, to the use of biological or synthetic glues and sea-
lants. A number of different types of surgical sealant have
been developed to prevent or reduce postoperative alveolar
air leaks, including: fibrin sealants, collagen fleeces, and
glutaraldehyde- or polyethylene glycol (PEG)-based syn-
thetic glues. Surgical sealants are particularly useful in
cases where PAL cannot be controlled by sutures or staples
alone.
Of the available surgical sealants, much of the lit-
erature has focused on CoSealW (Baxter Healthcare,
Deerfield, IL, USA), a biocompatible PEG polymer.
CoSealW is composed of two synthetic PEGs: a dilute
hydrogen chloride solution and a sodium phosphate/car-
bonate solution. At the time of administration, the solu-
tions combine to form a hydrogel, which cross-links
with proteins, causing immediate adherence to the
tissues. The sealant is completely absorbed by the body
within 30 days of application [14].
The aim of this prospective, randomized study was to
evaluate the role of a synthetic PEG matrix, CoSealW, in
reducing parenchymal air leaks detected by a digitalchest drainage system, DigiVent™, compared with stand-
ard treatment (suture and/or staples).
Methods
Patients
The study was conducted between March 2008 and
December 2011. A total of 1080 consecutive patients
who had undergone lung resections were enrolled. The
trial was approved by the Institutional Review Board of
the IRCCS-CROB Basilicata Regional Cancer Institute,
Rionero in Vulture, Italy, and was performed in accord-
ance with best practice in Italy. All patients provided
written informed consent prior to enrollment.
The inclusion criteria were: males or females ≥18 years
of age undergoing lung resection (bilobectomy or lobec-
tomy, anatomical and atypical segment resection) or
pleurectomy/decortication. Exclusion criteria were: im-
munodeficiency, patients undergoing bronchoplastic
procedures, and known hypersensitivity to any compo-
nent of the investigational products. Although CoSeal is
contraindicated in pleural decortications, we did not ex-
clude these patients (n = 3) because in our long experi-
ence we have not experienced any problems with
increased air leaks or inflammatory complications.
Surgical procedures
Resectability was evaluated by computed tomography
(CT) scan, bronchoscopy and mediastinoscopy, if indi-
cated. Operability was assessed by arterial blood gas ana-
lysis, pulmonary function tests, electrocardiogram and
echocardiography.
All pulmonary resections were performed at a single
institution by one of four attending thoracic surgeons
through an anterior-lateral muscle-sparing thoracotomy
in the 4th–5th intercostal space, or a video-assisted thor-
acoscopy. Mechanical staplers (EndoGIA 30 or 45–4.8 mm)
were used to develop incomplete fissures and close the bron-
chus (transverse anastomosis [TA] 30 mm). A complete
hilar-mediastinal lymphadenectomy was performed in all
patients.
After re-inflation of the operated lung (peak pressure
of 25 cm H2O), air leaks were detected by immersing
the lung in saline and rated as: 0 = no evidence of air
leak; 1 = moderate air leaks, characterized by non-
coalescent single bubbles; and 2 = severe air leaks, with
coalescent bubbles.
Patients with moderate or severe air leaks were rando-
mized to one of two groups: control group, in which
intraoperative air leaks were treated by direct manual or
stapler suture; or sealant group, in which air leaks were
treated with sutures/staples plus CoSealW. Following the
submersion test for air leaks, the surface to be treated
was dried to allow proper adherence of the sealant. The













Figure 1 Patient flow through the study.
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test for air tightness was performed; if there was still an
air leak, the sealant was reapplied and a third test was
subsequently conducted. In patients in the control
group, the persistence or absence of an air leak was
registered without further intervention. This study de-
sign was chosen to best reflect routine surgical practice,
where lung surgery patients who receive standard care
(sutures/staples and no sealant application) are closed
up without further intervention, even if an intraoperative
air leak persists. Similarly, in the sealant group, the pos-
sibility for a second application of the product reflects
the standard practice of sealant use by surgeons.
Chest tube management
Two 28 French multi-fenestrated chest tubes were posi-
tioned before the closure of the thoracotomy after lobecto-
mies, bilobectomies, and decortications: one anteriorly near
the apex and one in a postero-basal position. Patients who
underwent wedge resection had only one drain inserted,
with the exception of cases of severe bullous emphysema.
Chest drains were examined twice daily (once in the
morning and once in the afternoon) and withdrawn if
the volume of drained fluid was ≤250 ml in 24 h; pro-
vided there was no frank blood, the mean transpleural
air flow recorded by the digital system was <20 ml/min,
instantaneous air flow spikes were ≤200 ml/min and
radiological features excluded a pneumothorax >20% of
the operated hemithorax.
Randomization
Patients in which a moderate or severe air leak was
observed before thoracotomy closure were randomized
(1:1). Randomization was performed by a shuffled, sealed
envelope technique and envelopes containing the group
allocation were opened in the operating room.
Statistical analysis
The following postoperative variables were considered:
incidence of postoperative air leaks, defined as mean air
flow ≥20 ml/min recorded by the DigiVent™ software,
evidence of prolonged air leaks (defined as an air leak
lasting ≥5 days) and length of hospital stay.
Results are given as mean values. For categorical vari-
ables, the statistical significance of differences between
the control group and sealant group were determined
using the Chi-square test. Numerical variables were
compared using an unpaired Students t test. A p-value
of <0.05 was considered significant.
Results
Study population
Of the 1080 patients enrolled in the study, 222 patients
were randomized (1:1) to control (n = 111) or sealant(n = 111) (Figure 1). A total of six patients in the control
group were excluded from the analysis due to incom-
plete postoperative data. Therefore, a total of 105
patients were included in the analysis for the control
group (n = 71 males and n = 34 females) and a total of
111 patients (n = 65 males and n = 46 females) for the
sealant group.
The two treatment groups were comparable in terms
of gender distribution, mean age, ‘pack years’ (number of
years as a smoker, multiplied by the average number of
cigarettes smoked per day), mean preoperative forced
expiratory volume in one second (FEV1), mean predicted
postoperative FEV1 (ppoFEV1), pathology and surgical
procedures, as shown in Tables 1, 2 and 3.
Efficacy
The incidence of postoperative air leaks, defined as
mean transpleural air flow ≥20 ml/min in 24 h with in-
stantaneous air flow peaks ≥200 ml/min, as detected by
a digital chest drain system, was significantly lower in
the sealant group than the control group (sealant group:
12/111 patients, 10.8%; control group: 19/105 patients,
18.1%; p = 0.0002; Table 4).
Prolonged air leaks, defined as a leakage lasting be-
yond the 5th postoperative day, were recorded in 2.7%
(3/111) of patients in the sealant group and in 11.4%
(12/105) of patients in the control group. The lower in-
cidence of prolonged air leaks in the sealant group com-
pared with the control group was statistically significant
(p = 0.0013; Table 4).
The mean length of hospital stay was significantly
shorter in the sealant group than the control group
(4 versus 8 days; p < 0.0001) (Table 4). The mean number
of chest X-rays performed during the hospital stay was
three per patient.






Age (years) 67.5 65.3 0.1
FEV1 (%) 78.3 82.7 0.4
ppoFEV1 (%) 62.5 65.4 0.2
paO2 (mmHg) 82.1 80.3 0.3
paCO2 (mmHg) 39.2 38.6 0.5
Pack years* 48.0 46.7 0.05
Side (% right) 57.4 56.6 0.7a
Site (% upper lobes) 78.1 73.2 0.05a
Pleural adhesions (%) 43.2 40.5 0.1a
Stapler suture length (cm) 62.9 64.8 0.4
*The number of pack-years was calculated as the total number of years as a
smoker multiplied by the average number of cigarettes smoked per day,
divided by 20.
aChi-square test.
Results are mean values and based on the total population, unless stated
otherwise.
FEV1 and ppoFEV1 are expressed as percentage of predicted values for age,
gender and height.
FEV1 forced expiratory volume in one second, ppoFEV1 predicted postoperative
FEV1, paO2 partial pressure of oxygen, paCO2 partial pressure of carbon
dioxide.
Table 2 Patient characteristics: lung diseases
Diagnosis Control group n (%) Sealant group n (%)
Total n, (%) 105 (100.0) 111 (100.0)
Malignant disease 75 (71.5) 82 (73.9)
Primary lung neoplasm 52 (49.5) 47 (42.3)
Adenocarcinoma 33 (31.4) 18 (16.2)
Epidermoid 18 (17.1) 16 (14.4)
Bronchoalveolar 10 (9.52) 5 (4.50)
Poorly differentiated 5 (4.76) 3 (2.70)
Adenosquamous 3 (2.86) 1 (0.90)
Neuroendocrine 3 (2.86) 1 (0.90)
Typical carcinoid 3 (2.86) 2 (1.80)
Atypical carcinoid 0 (0.0) 1 (0.90)
Metastasis 23 (21.9) 35 (31.5)
Kidney 2 (1.90) 4 (3.60)
Ovarian 1 (0.95) 7 (6.31)
Skin 1 (0.95) 3 (2.70)
Salivary ducts 2 (1.90) 1 (0.90)
Prostatic 2 (1.90) 3 (2.70)
Breast 14 (13.3) 11 (9.91)
Colorectal 2 (1.90) 6 (5.40)
Benign disease 30 (28.6) 29 (26.1)
Flogistic 23 (21.9) 23 (20.7)
Disonthogenetic 5 (4.76) 5 (4.50)
Hydatid cyst 2 (1.90) 1 (0.90)
Table 3 Surgical procedures and approaches
Surgical procedure Control group n (%)
(N = 105)*
Sealant group n (%)
(N = 111)*
Parenchymal resections 101 (96.2) 108 (97.3)
Lobectomies 76 (72.4) 74 (66.7)
RUL 29 (27.6) 21 (18.9)
LUL 10 (9.5) 8 (7.2)
ML 5 (4.8) 2 (1.8)
RLL 14 (13.3) 21 (18.9)
LLL 15 (14.3) 20 (18.0)
LB 2 (1.9) 2 (1.8)
UB 1 (1.0) 0 (0.0)
Wedge resections 25 (23.8) 34 (30.6)
Decortications 4 (3.8) 3 (2.7)
*Total exceeds number of patients, as both surgical procedures and approaches
are reported.
RUL right upper lobectomy, LUL left upper lobectomy, ML middle lobectomy,
RLL right lower lobectomy, LLL left lower lobectomy, LB lower bilobectomy, UB
upper bilobectomy.
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Alveolar air leak is generally considered to be the most
important complication following lung resection and is
the leading cause of postoperative pulmonary morbidity,
prolonged length of hospital stay and increased hospital
costs.
Intraoperative air leaks following pulmonary resections
are reported in 48–70% of cases [15].
There are several studies that have observed that various
surgical sealants are safe and effective treatments for
intraoperative air leaks following lung resection [16-21].
Three prospective, randomized studies have recently
investigated the role of CoSealW in preventing, or reducing
the incidence of alveolar air leaks after lung resection
[16,21,22]. Similarly to our study, the results of two of
these studies observed that CoSealW can reduce the inci-
dence and duration of air leaks [16,21], whilst in contrast,
the third study did not observe any benefit conferred by
the use of CoSealW [22]. In the first study by Venuta et al.
[21], 50 patients undergoing standard pulmonary lobec-
tomy with incomplete or absent fissures were intraopera-






Mean air flow ≥20 ml/min
(n,%)
19 (18.1) 12 (10.8) 0.0002
Prolonged air leak (≥5 days)
(n,%)
12 (11.4) 3 (2.7) 0.0013*
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II received no sealants. The groups differed with respect
to duration of drainage, hospital stay, and presence of air
leakage during the first five days. A PAL (>7 days) was
present in 8% and 20% of patients in group I and group II,
respectively. The authors concluded that the use of
CoSealW in selected cases may help to reduce the inci-
dence and duration of air leaks [21].
The second study by D’Andrilli et al. [16] evaluated
the effectiveness and safety of CoSealW in reducing
air leaks in patients undergoing lung resection with
reinforcement of the stapled line by bovine pericardial
strips in case of incomplete fissure. In total, 203 patients
undergoing anatomic or atypical lung resection were en-
rolled. Patients showing moderate or severe air leaks
were intraoperatively randomized to either the standard
care group (suture-stapling) or the CoSealW group
(suture-stapling plus CoSealW). The intraoperative air leak
cessation rate was significantly higher in the CoSealW
group compared with the standard care group. In addition,
the CoSealW group showed a significantly lower rate of air
leaks after 24 and 48 h [16]. The application of CoSealW
sealant proved effective in reducing air leaks and in short-
ening the duration of PAL.
The third study by Tan et al. [22] evaluated the effective-
ness of CoSealW in reducing the duration of air leaks in
patients undergoing lung resection. Patients who experi-
enced an intraoperative air leak during the underwater air-
tightness test were randomized to either the CoSealW
group or standard care group. At 24 h, there was no differ-
ence in air leak between the groups and fewer patients in
the control group were leaking at 48 h postoperatively [22].
Possible reasons for the conflicting results of this study
[22] with those of D’Andrilli et al. [16], Venuta et al. [21]
and our study, could be due to the inclusion of approxi-
mately 40% of the patient poulation in the Tan et al. study
with mild (Grade 1) intraoperative air leaks, which usually
have a rapid, spontaneous resolution, and differences in
the dose of product applied in each patient [23]. Addition-
ally, in contrast to our study, postoperative air leaks in
these studies [16,21,22] were detected by an analogical
chest drainage system, so air leaks could not be accurately
measured. The detection of air leaks has recently been
improved by the addition of digital units to chest drains.
The prototype digital chest drain is DigiVent™, which con-
sists of a collection chamber, equipped with a unidirec-
tional dry valve, digital displays, and software that can
assess and record instantaneous and cumulative air flows
and pleural pressures. In our experience, the use of digital
chest drain systems in patients undergoing parenchymal
resection, or other procedures in which sealants have been
applied, has yielded exciting results.
In our study, the incidence of air leaks detected by
DigiVent™ was significantly lower in patients treatedwith CoSealW compared with controls (10.8% versus
18.1%, respectively). Moreover, there was a significantly
higher incidence of prolonged air leaks in the control
group compared with the CoSealW group (11.4% versus
2.7%, respectively). The mean hospital stay was shorter
amongst patients treated with CoSealW compared with
controls, which may translate into associated cost
savings. In the present study, CoSealW demonstrated
superior air sealing efficacy compared with standard care
in patients with good pulmonary function, showing a
significantly reduced proportion of patients with air
leaks and lower mean air leak volume.
CoSealW may be expected to be even more effective in
high-risk patients who may be predisposed to fragile, poor
quality lung parenchyma (e.g., patients with chronic
obstructive pulmonary disease ([COPD], inflammation or
apical fibrosis). However, further stratification of patients
is required in order to evaluate the advantages of continu-
ous digital recording of air leaks following sealant app-
lication in high-risk cohorts (e.g. COPD) and patients
undergoing upper lobe resections. These studies could
also include investigations relating to the extent of paren-
chymal resection (in terms of suture line length) and the
characteristics of staplers. Such studies would provide
interesting information concerning the prevention, early
recognition and treatment of air leaks in a larger number
of patients.
Conclusions
The results of this study suggest that CoSealW is an
effective method of reducing postoperative alveolar air
leaks, continuously monitored using the DigiVent™
system, in patients undergoing elective lung resection. In
our opinion, the use of CoSealW could have a favorable
impact on patient compliance, as well as reducing the
length of hospital stays and associated costs.
Abbreviations
COPD: Chronic obstructive pulmonary disease; CT: Computed tomography;
FEV1: Forced expiratory volume in one second; LB: Lower bilobectomy;
LLL: Left lower lobectomy; LUL: Left upper lobectomy; ML: Middle
lobectomy; paCO2: Partial pressure of carbon dioxide; paO2: Partial pressure
of oxygen; PAL: Prolonged air leaks; PEG: Polyethylene glycol;
ppoFEV1: Predicted postoperative FEV1; RLL: Right lower lobectomy;
RUL: Right upper lobectomy; UB: Upper bilobectomy.
Competing interests
No sources of funding were used to support the study. The authors had full
control of the design of the study, methods used, outcome parameters and
results, analysis of data and production of the written report. All authors
declare that they have no competing interests.
Authors’ contributions
CL participated in the design of the study and its coordination and helped
to draft the manuscript. GG participated in the design of the study and
helped to draft the manuscript. RM participated in the design of the study,
participated in the sequence alignment and helped to draft the manuscript.
ADM participated in the design of the study, participated in the sequence
alignment and helped to draft the manuscript. MG performed the statistical
analysis. All authors read and approved the final manuscript.
Lequaglie et al. Journal of Cardiothoracic Surgery 2012, 7:106 Page 6 of 6
http://www.cardiothoracicsurgery.org/content/7/1/106Acknowledgements
Editorial assistance was provided by Fishawack Communications Ltd (UK);
this assistance was funded by Baxter BioSurgery, Italy.
Author details
1Department of Thoracic Surgery, IRCCS-CROB Centro Riferimento
Oncologico Basilicata, Rionero in Vulture, PZ, Italy. 2Basilicata Regional Health
Department, Potenza, Italy. 3Department of Thoracic Surgery, IRCCS-CROB
Centro Riferimento Oncologico Basilicata, Via Padre Pio n° 1, 85028, Rionero
in Vulture, PZ, Italy.
Received: 8 May 2012 Accepted: 20 September 2012
Published: 8 October 2012References
1. Varela G, Jimenez MF, Novoa N, Aranda JL: Estimating hospital costs
attributable to prolonged air leak in pulmonary lobectomy.
Eur J Cardiothorac Surg 2005, 27:329–333.
2. Cerfolio RJ, Bass CS, Pask AH, Katholi CR: Predictors and treatment of
persistent air leaks. Ann Thorac Surg 2002, 73:1727–1730.
3. Singhal S, Ferraris VA, Bridges CR, Clough ER, Mitchell JD, Fernando HC,
Shrager JB: Management of alveolar air leaks after pulmonary resection.
Ann Thorac Surg 2010, 89:1327–1335.
4. Brunelli A, Monteverde M, Borri A, Salati M, Marasco RD, Fianchini A:
Predictors of prolonged air leak after pulmonary lobectomy. Ann Thorac
Surg 2004, 77:1205–1210.
5. Brunelli A, Al Refai M, Monteverde M, Borri A, Salati M, Sabbatini A, Fianchini
A: Pleural tent after upper lobectomy: a randomized study of efficacy
and duration of effect. Ann Thorac Surg 2002, 74:1958–1962.
6. Carboni GL, Vogt A, Kuster JR, Berg P, Wagnetz D, Schmid RA, Dutly AE:
Reduction of airspace after lung resection through controlled paralysis
of the diaphragm. Eur J Cardiothorac Surg 2008, 33:272–275.
7. De Giacomo T, Rendina EA, Venuta F, Francioni F, Moretti M, Pugliese F,
Coloni GF: Pneumoperitoneum for the management of pleural air space
problems associated with major pulmonary resections. Ann Thorac Surg
2001, 72:1716–1719.
8. Temes RT, Willms CD, Endara SA, Wernly JA: Fissureless lobectomy.
Ann Thorac Surg 1998, 65:282–284.
9. Brunelli A, Salati M, Refai M, Di Nunzio L, Xiume F, Sabbatini A: Evaluation
of a new chest tube removal protocol using digital air leak monitoring
after lobectomy: a prospective randomised trial. Eur J Cardiothorac Surg
2010, 37:56–60.
10. Cerfolio RJ, Bryant AS: The benefits of continuous and digital air leak
assessment after elective pulmonary resection: a prospective study.
Ann Thorac Surg 2008, 86:396–401.
11. Dernevik L, Belboul A, Radberg G: Initial experience with the world’s first
digital drainage system. The benefits of recording air leaks with graphic
representation. Eur J Cardiothorac Surg 2007, 31:209–213.
12. Varela G, Brunelli A, Jimenez MF, Di Nunzio L, Novoa N, Aranda JL, Sabbatini
A: Chest drainage suction decreases differential pleural pressure after
upper lobectomy and has no effect after lower lobectomy.
Eur J Cardiothorac Surg 2010, 37:531–534.
13. Varela G, Jimenez MF, Novoa NM, Aranda JL: Postoperative chest tube
management: measuring air leak using an electronic device decreases
variability in the clinical practice. Eur J Cardiothorac Surg 2009,
35:28–31.
14. Baxter Healthcare D: CoSeal package insert. IL: 2006. Availiable at http://www.
baxter.com/downloads/healthcare_professionals/products/CoSeal_PI.pdf.
15. Lang G, Csekeo A, Stamatis G, Lampl L, Hagman L, Marta GM, Mueller MR,
Klepetko W: Efficacy and safety of topical application of human
fibrinogen/thrombin-coated collagen patch (TachoComb) for treatment
of air leakage after standard lobectomy. Eur J Cardiothorac Surg 2004,
25:160–166.
16. D’Andrilli A, Andreetti C, Ibrahim M, Ciccone AM, Venuta F, Mansmann U,
Rendina EA: A prospective randomized study to assess the efficacy of a
surgical sealant to treat air leaks in lung surgery. Eur J Cardiothorac Surg
2009, 35:817–820.
17. Dango S, Lin R, Hennings E, Passlick B: Initial experience with a synthetic
sealant PleuraSeal after pulmonary resections: a prospective study with
retrospective case matched controls. J Cardiothorac Surg 2010, 5:50.18. De Leyn P, Muller MR, Oosterhuis JW, Schmid T, Choong CK, Weder W,
Sokolow Y: Prospective European multicenter randomized trial of
PleuraSeal for control of air leaks after elective pulmonary resection.
J Thorac Cardiovasc Surg 2011, 141:881–887.
19. Gonfiotti A, Santini PF, Jaus M, Janni A, Lococo A, De Massimi AR,
D’Agostino A, Carleo F, Di Martino M, Larocca V, Cardillo G: Safety and
effectiveness of a new fibrin pleural air leak sealant: a multicenter,
controlled, prospective, parallel-group, randomized clinical trial.
Ann Thorac Surg 2011, 92:1217–1224. discussion 1224–1215.
20. Malapert G, Hanna HA, Pages PB, Bernard A: Surgical sealant for the
prevention of prolonged air leak after lung resection: meta-analysis. Ann
Thorac Surg 2010, 90:1779–1785.
21. Venuta F, Diso D, De Giacomo T, Anile M, Rendina EA, Coloni GF: Use of a
polymeric sealant to reduce air leaks after lobectomy. J Thorac Cardiovasc
Surg 2006, 132:422–423.
22. Tan C, Utley M, Paschalides C, Pilling J, Robb JD, Harrison-Phipps KM, Lang-
Lazdunski L, Treasure T: A prospective randomized controlled study to
assess the effectiveness of CoSeal(R) to seal air leaks in lung surgery.
Eur J Cardiothorac Surg 2011, 40:304–308.
23. D’Andrilli A, Rendina EA: A prospective randomized trial to assess the
effectiveness of Coseal to seal air leaks in lung surgery. Eur J Cardiothorac
Surg 2012, 41:968–969.
doi:10.1186/1749-8090-7-106
Cite this article as: Lequaglie et al.: Use of a sealant to prevent
prolonged air leaks after lung resection: a prospective randomized
study. Journal of Cardiothoracic Surgery 2012 7:106.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
